Literature DB >> 1011021

Weakness associated with the pathological presence of lipid in skeletal muscle: a detailed study of a patient with carnitine deficiencey.

H Isaacs, J J Heffron, M Badenhorst, A Pickering.   

Abstract

A patient with muscular weakness demonstrating pathological lipid accumulation and abnormal mitochondria in skeletal muscle has been studied. The lipid accumulation and mitochondrial changes are thought to be related to the established deficiency of carnitine in this patient's muscle. The symptoms of muscular weakness associated with lipid accumulation in the skeletal muscle in the absence of complaint of muscle cramps or myglobinuria are thought to be diagnostic of carnitine deficiency. The failure of the sarcoplasmic reticulum to accumulate Ca2+ is discussed. The patient's strength responded dramatically when propranolol was added to his steroid therapy.

Entities:  

Mesh:

Substances:

Year:  1976        PMID: 1011021      PMCID: PMC1083312          DOI: 10.1136/jnnp.39.11.1114

Source DB:  PubMed          Journal:  J Neurol Neurosurg Psychiatry        ISSN: 0022-3050            Impact factor:   10.154


  23 in total

1.  LONG-CHAIN CARNITINE ACYLTRANSFERASE AND THE ROLE OF ACYLCARNITINE DERIVATIVES IN THE CATALYTIC INCREASE OF FATTY ACID OXIDATION INDUCED BY CARNITINE.

Authors:  I B FRITZ; K T YUE
Journal:  J Lipid Res       Date:  1963-07       Impact factor: 5.922

2.  THE DISTRIBUTION OF CARNITINE, ACETYLCARNITINE, AND CARNITINE ACETYLTRANSFERASE IN RAT TISSUES.

Authors:  N R MARQUIS; I B FRITZ
Journal:  J Biol Chem       Date:  1965-05       Impact factor: 5.157

3.  The familial occurrence of fat containing vacuoles in the leukocytes diagnosed in two brothers suffering from dystrophia musculorum progressiva (ERB.).

Authors:  G H JORDANS
Journal:  Acta Med Scand       Date:  1953

4.  Protein measurement with the Folin phenol reagent.

Authors:  O H LOWRY; N J ROSEBROUGH; A L FARR; R J RANDALL
Journal:  J Biol Chem       Date:  1951-11       Impact factor: 5.157

5.  A myopathy associated with lipid storage.

Authors:  W G Bradley; M Jenkison; D C Park; P Hudgson; D Gardner-Medwin; R J Pennington; J N Walton
Journal:  J Neurol Sci       Date:  1972-06       Impact factor: 3.181

6.  Serum carnitine. An index of muscle destruction in man.

Authors:  S DiMauro; C Scott; A S Penn; L P Rowland
Journal:  Arch Neurol       Date:  1973-03

7.  Lipid storage myopathy responsive to prednisone.

Authors:  A G Engel; R G Siekert
Journal:  Arch Neurol       Date:  1972-08

8.  Evolution and content of vacuoles in primary hypokalemic periodic paralysis.

Authors:  A G Engel
Journal:  Mayo Clin Proc       Date:  1970 Nov-Dec       Impact factor: 7.616

9.  Carnitine deficiency of human skeletal muscle with associated lipid storage myopathy: a new syndrome.

Authors:  A G Engel; C Angelini
Journal:  Science       Date:  1973-03-02       Impact factor: 47.728

10.  Two childhood myopathies with abnormal mitochondria. I. Megaconial myopathy. II. Pleoconial myopathy.

Authors:  G M Shy; N K Gonatas; M Perez
Journal:  Brain       Date:  1966-03       Impact factor: 13.501

View more
  5 in total

1.  Autosomal recessive lipid storage myopathy (probable carnitine deficiency).

Authors:  C Almog; K Fried; R Reif; J Zieghelboim; G Lewinsohn
Journal:  J Med Genet       Date:  1979-12       Impact factor: 6.318

2.  "Carnitine deficient" myopathy and cardiomyopathy with fatal outcome.

Authors:  F Cornelio; S Di Donato; D Testa; M Mora; G Gori; D Peluchetti; M Rimoldi
Journal:  Ital J Neurol Sci       Date:  1980-03

3.  A hereditary case of lipid storage myopathy with carnitine deficiency. Ultrastructural observation of muscle tissue in parents.

Authors:  G Pellegrini; G Scarlato; M Moggio
Journal:  J Neurol       Date:  1980       Impact factor: 4.849

4.  Lipid storage myopathy: successful treatment with propranolol.

Authors:  C Martyn; E H Jellinek; J N Webb
Journal:  Br Med J (Clin Res Ed)       Date:  1981-06-20

5.  Muscular carnitine synthesis and palmitate metabolism in vitro.

Authors:  G Scarlato; G Meola; E Scarpini; C Cerri
Journal:  J Neurol       Date:  1978-06-16       Impact factor: 4.849

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.